The vaccine against the coronavirus produced in Argentina will be available by the end of the beginning of 2023, This was announced at a meeting between national authorities and scientists, which was held at Casa Rosada.
Immunization ARVAC-Cecilia Grierson will begin testing on volunteers next January and growers expect these tests to end during the final weeks of 2022. The vaccine It is developed at UNSAM (University of San Martín de los Andes).
To get into the advances of the vaccine, the President of the Nation, Alberto Fernndez, and the Minister of Health, Carla Vizzotti, met with the heads of CONICET and FONARSEC (Argentine Sector Fund), Ana Franchi and Laura Toledo.
I am proud of our science and technology, which is taking another step forward, said the head of state during the meeting in which the Minister of Science and Technology, Daniel Filmus, also participated.
It makes us enormously sovereign, value the president in reference to the advances of the frmaco 100% made on Argentine soil. For its part, Filmus stressed that the president wanted to greet the different research groups that responded to the Government’s call.
How were the preclinical tests of the vaccine
Preclinical tests of the vaccine were shown to be effective against the virus and toxicological tests are now being carried out at the CMC (Comparative Medicine Center) of the UNL (Universidad Nacional del Litoral).
Once these studies are completed, the protocols for the Phase 1 trial, to be performed in humans, will be sent to ANMAT (National Administration of Medicines, Food and Medical Technology) for validation.
“While they are not going to replace the other vaccines, we are going to have an action of our own. The WHO (World Health Organization) has defined that Argentina and Brazil have the conditions for the production of vaccines, and we are going to work towards that, said Filmus to the media present after the meeting.